Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/ACTICOR-BIOTECH-SAS-128303565/nieuws/Acticor-Biotech-kondigt-positieve-resultaten-aan-van-zijn-ACTIMIS-PHASE-1b-2a-studie-bij-patienten-39540906/?utm_source=whatsapp&utm_medium=social&utm_campaign=share